Role of docosahexaenoic acid treatment in improving liver histology in pediatric nonalcoholic fatty liver disease

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Nobili, Valerio ^a   Carpino, Guido ^b   Alisi, Anna ^a   De Vito, Rita ^a   Franchitto, Antonio ^c,d   Alpini, Gianfranco ^e   Onori, Paolo ^c   Gaudio, Eugenio ^c  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF ROME FORO ITALICO   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Eleonora Lorillard Spencer Cenci Foundation   (Italy)

^e TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CYTOKERATIN 7; DOCOSAHEXAENOIC ACID; EPITHELIAL CELL ADHESION MOLECULE; G PROTEIN COUPLED RECEPTOR 120; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; SERINE; TRIACYLGLYCEROL;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL SURVIVAL; CHILD; CLINICAL ARTICLE; FATTY LIVER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER BIOPSY; LIVER CELL; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; NONALCOHOLIC FATTY LIVER; POLARIZATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; STEM CELL;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; CHILD; CYTOKINES; DOCOSAHEXAENOIC ACIDS; FATTY LIVER; FEMALE; HEPATOCYTES; HUMANS; INFLAMMATION; LIVER; MACROPHAGES; MALE; NF-KAPPA B; RECEPTORS, G-PROTEIN-COUPLED; STEM CELLS;

EID: 84895134865     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088005     Document Type: Article

References (34)

1. Alisi A, Feldstein AE, Villani A, Raponi M, Nobili V (2012) Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach. Nat Rev Gastroenterol Hepatol 9: 152-161.
2. Carpino G, Renzi A, Onori P, Gaudio E (2013) Role of Hepatic Progenitor Cells in Nonalcoholic Fatty Liver Disease Development: Cellular Cross-Talks and Molecular Networks. Int J Mol Sci 14: 20112-20130.
3. Nobili V, Carpino G, Alisi A, Franchitto A, Alpini G, et al. (2012) Hepatic progenitor cells activation, fibrosis and adipokines production in pediatric nonalcoholic fatty liver disease. Hepatology 56: 2142-2153.
4. Masterton GS, Plevris JN, Hayes PC (2010) Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease. Aliment Pharmacol Ther 31: 679-692.
5. Parker HM, Johnson NA, Burdon CA, Cohn JS, O'Connor HT, et al. (2012) Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 56: 944-951.
6. Capanni M, Calella F, Biagini MR, Genise S, Raimondi L, et al. (2006) Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. Aliment Pharmacol Ther 23: 1143-1151. (Pubitemid 43779354)
7. Pettinelli P, Del Pozo T, Araya J, Rodrigo R, Araya AV, et al. (2009) Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion. Biochim Biophys Acta 1792: 1080-1086.
8. Nobili V, Alisi A, Della Corte C, Rise P, Galli C, et al. (2012) Docosahexaenoic acid for the treatment of fatty liver: Randomised controlled trial in children. Nutr Metab Cardiovasc Dis.
9. Nobili V, Bedogni G, Alisi A, Pietrobattista A, Rise P, et al. (2011) Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial. Arch Dis Child 96: 350-353.
10. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, et al. (2010) GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142: 687-698.
11. Depner CM, Philbrick KA, Jump DB (2013) Docosahexaenoic Acid Attenuates Hepatic Inflammation, Oxidative Stress, and Fibrosis without Decreasing Hepatosteatosis in a Ldlr-/- Mouse Model of Western Diet-Induced Nonalcoholic Steatohepatitis. J Nutr.
12. Nobili V, Manco M, Devito R, Di Ciommo V, Comparcola D, et al. (2008) Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 48: 119-128. (Pubitemid 351975537)
13. Shannon A, Alkhouri N, Carter-Kent C, Monti L, Devito R, et al. (2011) Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD. J Pediatr Gastroenterol Nutr 53: 190-195.
14. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-1321. (Pubitemid 40770284)
15. Brunt EM (2001) Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 21: 3-16.
16. Alkhouri N, De Vito R, Alisi A, Yerian L, Lopez R, et al. (2012) Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease. J Hepatol 57: 1312-1318.
17. Glaser S, Lam IP, Franchitto A, Gaudio E, Onori P, et al. (2010) Knockout of secretin receptor reduces large cholangiocyte hyperplasia in mice with extrahepatic cholestasis induced by bile duct ligation. Hepatology 52: 204-214.
18. Glaser SS, Gaudio E, Rao A, Pierce LM, Onori P, et al. (2009) Morphological and functional heterogeneity of the mouse intrahepatic biliary epithelium. Lab Invest 89: 456-469.
19. Roskams TA, Theise ND, Balabaud C, Bhagat G, Bhathal PS, et al. (2004) Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology 39: 1739-1745. (Pubitemid 38702678)
20. Spee B, Carpino G, Schotanus BA, Katoonizadeh A, Vander Borght S, et al. (2010) Characterisation of the liver progenitor cell niche in liver diseases: potential involvement of Wnt and Notch signalling. Gut 59: 247-257.
21. Katoonizadeh A, Nevens F, Verslype C, Pirenne J, Roskams T (2006) Liver regeneration in acute severe liver impairment: a clinicopathological correlation study. Liver Int 26: 1225-1233. (Pubitemid 44741210)
22. Carpino G, Cardinale V, Onori P, Franchitto A, Berloco PB, et al. (2012) Biliary tree stem/progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineages. J Anat 220: 186-199.
23. Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA (2011) Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 53: 810-820.
24. Yoon SM, Gerasimidou D, Kuwahara R, Hytiroglou P, Yoo JE, et al. (2011) Epithelial cell adhesion molecule (EpCAM) marks hepatocytes newly derived from stem/progenitor cells in humans. Hepatology 53: 964-973.
25. Trzpis M, McLaughlin PM, de Leij LM, Harmsen MC (2007) Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule. Am J Pathol 171: 386-395. (Pubitemid 47344671)
26. Nobili V, Alisi A, Della Corte C, Rise P, Galli C, et al. (2012) Docosahexaenoic acid for the treatment of fatty liver: Randomised controlled trial in children. Nutr Metab Cardiovasc Dis 23: 1066-1070.
27. Ichimura A, Hirasawa A, Poulain-Godefroy O, Bonnefond A, Hara T, et al. (2012) Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 483: 350-354.
28. Talukdar S, Olefsky JM, Osborn O (2011) Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases. Trends Pharmacol Sci 32: 543-550.
29. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953-964. (Pubitemid 41746764)
30. Lumeng CN, Saltiel AR (2011) Inflammatory links between obesity and metabolic disease. J Clin Invest 121: 2111-2117.
31. Boulter L, Govaere O, Bird TG, Radulescu S, Ramachandran P, et al. (2012) Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med 18: 572-579.
32. Gaudio E, Carpino G, Cardinale V, Franchitto A, Onori P, et al. (2009) New insights into liver stem cells. Dig Liver Dis 41: 455-462.
33. Dela Pena A, Leclercq I, Field J, George J, Jones B, et al. (2005) NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis. Gastroenterology 129: 1663-1674. (Pubitemid 41597405)
34. Li L, Chen L, Hu L, Liu Y, Sun HY, et al. (2011) Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice. Hepatology 54: 1620-1630.